About Tagworks Pharmaceuticals
Tagworks Pharmaceuticals is a company based in Nijmegen (Netherlands) founded in 2011 by Zach Taylor and Marc Robillard.. Tagworks Pharmaceuticals has raised $65 million across 5 funding rounds from investors including European Union, Oost NL and Ysios Capital. Tagworks Pharmaceuticals offers products and services including Click-to-Release Technology and TGW101. Tagworks Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
- Headquarter Nijmegen, Netherlands
- Founders Zach Taylor, Marc Robillard
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tagworks Pharmaceuticals Bv
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65 M (USD)
in 5 rounds
-
Latest Funding Round
$65 M (USD), Series A
Jun 22, 2023
-
Investors
European Union
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tagworks Pharmaceuticals
Tagworks Pharmaceuticals offers a comprehensive portfolio of products and services, including Click-to-Release Technology and TGW101. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates controlled release of cancer drugs via click chemistry
Targets non-internalizing markers for solid tumor treatment
Unlock access to complete
Funding Insights of Tagworks Pharmaceuticals
Tagworks Pharmaceuticals has successfully raised a total of $65M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $65 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $65.0M
-
First Round
First Round
(01 Feb 2015)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series A - Tagworks Pharmaceuticals | Valuation | Ysios Capital , Gilde Healthcare | |
| Mar, 2023 | Amount | Grant - Tagworks Pharmaceuticals | Valuation |
investors |
|
| Mar, 2018 | Amount | Grant - Tagworks Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tagworks Pharmaceuticals
Tagworks Pharmaceuticals has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Oost NL and Ysios Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ysios Capital is recognized as a leading life sciences investor.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tagworks Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tagworks Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tagworks Pharmaceuticals Comparisons
Competitors of Tagworks Pharmaceuticals
Tagworks Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tagworks Pharmaceuticals
Frequently Asked Questions about Tagworks Pharmaceuticals
When was Tagworks Pharmaceuticals founded?
Tagworks Pharmaceuticals was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is Tagworks Pharmaceuticals located?
Tagworks Pharmaceuticals is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Who is the current CEO of Tagworks Pharmaceuticals?
Ken Mills is the current CEO of Tagworks Pharmaceuticals.
Is Tagworks Pharmaceuticals a funded company?
Tagworks Pharmaceuticals is a funded company, having raised a total of $65M across 5 funding rounds to date. The company's 1st funding round was a Grant of $313.33K, raised on Feb 01, 2015.
What does Tagworks Pharmaceuticals do?
Tagworks Pharmaceuticals was founded in 2011 in Nijmegen, Netherlands, within the biotechnology sector focused on oncology. Antibody-drug conjugates targeting solid tumors, including the lead product TGW101 against TAG72, are developed. Solid-tumor-targeted ADCs and radiopharmaceuticals, such as a HER2-targeted radioimmunotherapeutic, are also offered. Operations center on innovative therapies for various carcinomas, with clinical validation emphasized for non-internalizing targets.
Who are the top competitors of Tagworks Pharmaceuticals?
Tagworks Pharmaceuticals's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Tagworks Pharmaceuticals offer?
Tagworks Pharmaceuticals offers Click-to-Release Technology and TGW101.
Who are Tagworks Pharmaceuticals's investors?
Tagworks Pharmaceuticals has 8 investors. Key investors include European Union, Oost NL, Ysios Capital, Gilde Healthcare, and Novartis Venture Fund.